Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Axcan completes acquisition of U.S. rights to Viokase

Sep. 5, 1997

Preclinical results with L-FMAU, an anti-HBV agent

Sep. 3, 1997

NDA for Colazide accepted for review by FDA

Sep. 1, 1997

New indication approved for Asacol

Aug. 28, 1997

Eurand and Global enter pancrelipase agreement

Aug. 28, 1997

Antioxidant properties of T-593 contribute to gastroprotection in the rat

Aug. 27, 1997

BioChem Pharma files first marketing application for lamivudine in hepatitis

Aug. 27, 1997

HemoCleanse receives NIH grant to develop bioartificial liver

Aug. 25, 1997

GalaGen starts Diffistat-G phase II trial

Aug. 18, 1997

Phase I trial of DiffGAM completed successfully

Aug. 18, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...